Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

APL

Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience

Leukemia volume 19, pages 230–233 (2005)Cite this article

Abstract

We analyzed the outcome of patients aged more than 60 included in a multicenter trial in newly diagnosed acute promyelocytic leukemia (APL93 trial), which tested the role of early addition of chemotherapy to all trans retinoic acid (ATRA) and of maintenance with ATRA and/or low-dose chemotherapy. In total, 129/533 (24.2%) patients included in this trial were older than 60. The CR rate was 86% in patients older than 60 as compared to 94.5% in younger patients (P=0.0014), due to a higher incidence of early deaths in elderly patients. The 4-year incidence of relapse was 15.6% in adults older than 60 and 23.2% in younger adults although most elderly patients received less intensive consolidation chemotherapy. However, 18.6% of the patients older than 60 years who achieved CR died in CR, mainly from sepsis during consolidation course or maintenance treatment, as compared to 5.7% of younger adults (P<0.001). Thus, overall 4-year survival of elderly patients was 57.8% as compared to 78% in younger adults (P<0.0001). APL in elderly patients appears as sensitive to ATRA-Chemotherapy based regimen as in younger adults. Less favorable outcome is mainly due to an increase of early deaths and to toxicity of consolidation treatment, strongly suggesting a beneficial role for less intensive consolidation chemotherapy and possibly introduction of arsenic derivates in the treatment of APL in the elderly.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Fenaux P, Chomienne C, Degos L . All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol 2001; 38: 13–25.

    Article  CAS  PubMed  Google Scholar 

  2. Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E et al. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 1999; 94: 1192–1200.

    CAS  PubMed  Google Scholar 

  3. Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T et al. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group. Blood 1995; 85: 1202–1206.

    CAS  PubMed  Google Scholar 

  4. Sanz MA, Martin G, Gonzalez M, Leon A, Rayon C, Rivas C et al. Programa de Estudio y Traitmiento de las Hemopatias Malignas. Risk-adapted treatment of acute promyelocytic leukemia with all-transretinoic acid and anthracycline monochemotherapy: a multicenter study the PETHEMA group. Blood 2004; 103: 1237–1243.

    Article  CAS  PubMed  Google Scholar 

  5. Sanz M, Vellenga E, Rayon C, Diaz-Mediavilla J, Rivas C, Amutio E et al. All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia. Blood 2004, August 3 [E-pub ahead of print].

  6. Warrell Jr RP, Maslak P, Eardley A, Heller G, Miller Jr WH, Frankel SR . Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Leukemia 1994; 8: 929–933.

    PubMed  Google Scholar 

  7. de Botton S, Coiteux V, Chevret S, Rayon C, Vilmer E, Sanz M et al. Outcome of childhood acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy. J Clin Oncol 2004; 22: 1404–1412.

    Article  CAS  PubMed  Google Scholar 

  8. Mandelli F, Latagliata R, Avvisati G, Fazi P, Rodeghiero F, Leoni F et al. Treatment of elderly patients (&gt;or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA w&lt;ith ATRA and idarubicin (AIDA) protocols. Leukemia 2003; 17: 1085–1090.

    Article  CAS  PubMed  Google Scholar 

  9. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451–458.

    Article  CAS  PubMed  Google Scholar 

  10. Fenaux P, Pollet JP, Vandenbossche-Simon JL . Treatment of acute promyelocytic leukemia. A report on 70 cases. Leukemia Lymphoma 1991; 4: 239–246.

    Article  CAS  PubMed  Google Scholar 

  11. Cunningham I, Gee TS, Reich LM, Kempin SJ, Naval AN, Clarkson BD . Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. Blood 1989; 73: 1116–1122.

    CAS  PubMed  Google Scholar 

  12. Burnett AK, Grimwade D, Solomon E, Wheatley K, Goldstone AH . Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial. Blood 1999; 93: 4131–4143.

    CAS  PubMed  Google Scholar 

  13. Hiddemann W, Kern W, Schoch C, Fonatsch C, Heinecke A, Wormann B et al. Management of acute myeloid leukemia in elderly patients. J Clin Oncol 1999; 17: 3569–3576.

    Article  CAS  PubMed  Google Scholar 

  14. Estey E, Thall PF, Pierce S, Kantarjian H, Keating M . Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine. J Clin Oncol 1997; 15: 483–490.

    Article  CAS  PubMed  Google Scholar 

  15. Niu C, Yan H, Yu T, Sun HP, Liu JX, Li XS et al. Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood 1999; 94: 3315–3324.

    CAS  PubMed  Google Scholar 

  16. Lu DP, Qiu JY, Jiang B, Wang Q, Liu KY, Liu YR et al. Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report. Blood 2002; 99: 3136–3143.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d'hématologie clinique/Hôpital Avicenne, Paris XIII University, Bobigny, France

    L Ades, S Chevret, S De Botton, X Thomas, H Dombret, B Beve, M Sanz, A Guerci, J S Miguel, J dela Serna, C Garo, A M Stoppa, O Reman, A Stamatoulas, M Fey, J Y Cahn, J J Sotto, J H Bourhis, A Parry, C Chomienne, L Degos & P Fenaux

Authors
  1. L Ades
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Chevret
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S De Botton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. X Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H Dombret
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B Beve
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Sanz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Guerci
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J S Miguel
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J dela Serna
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. C Garo
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A M Stoppa
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. O Reman
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. A Stamatoulas
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. M Fey
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. J Y Cahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. J J Sotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. J H Bourhis
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. A Parry
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. C Chomienne
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. L Degos
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. P Fenaux
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

For the European APL Group

Corresponding author

Correspondence to P Fenaux.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ades, L., Chevret, S., De Botton, S. et al. Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience. Leukemia 19, 230–233 (2005). https://doi.org/10.1038/sj.leu.2403597

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403597

Keywords

This article is cited by

Search

Advanced search

Quick links